Skip to main content

Day: November 16, 2021

UBISOFT ANNOUNCES THE OPENING OF A NEW STUDIO IN SHERBROOKE AND A MAJOR INVESTMENT PROGRAM IN QUEBEC

UBISOFT ANNOUNCES THE OPENING OF A NEW STUDIO IN SHERBROOKE AND A MAJOR INVESTMENT PROGRAM IN QUEBEC Download the Press Release SHERBROOKE, November 16, 2021 – Ubisoft is announcing the opening of a fourth video game development studio in Quebec, in the city of Sherbrooke known as the academic and economic hub of the Eastern Townships. This new studio reaffirms Ubisoft’s commitment as a major economic player serving the province’s talent, communities and ecosystems. In the presence of Mr. Pierre Fitzgibbon, Minister of Economy and Innovation and Minister Responsible for Regional Economic Development and Ms. Évelyne Beaudin, Mayor of Sherbrooke, Mr. Yves Guillemot, Co-Founder and CEO of Ubisoft, and Ms. Nathalie Jasmin, Director of the Ubisoft Sherbrooke studio, made the announcement today, marking another milestone in Ubisoft’s development...

Continue reading

AB Linas Agro Group: notification on transactions in the issuer’s securities by the managers and persons closely associated with the managers of the Company

AB Linas Agro Group (further – Company, Issuer) has received notifications of the managers and of the persons closely associated with the managers of the Company about transactions in the Issuers’s securities (enclosed).   Additional information: Mažvydas Šileika, Finance Director of AB Linas Agro Group Mob. +370 619 19 403 E-mail m.sileika@linasagro.ltAttachmentsNotification and public disclosure of transactions by persons discharging managerial, LPINotification and public disclosure of transactions by persons discharging managerial, APR

Continue reading

Correction: Flex LNG – Key Information Relating to the Cash Dividend for Third Quarter 2021

Correction to the date of payment of dividends in NOK to shares held with Euronext VPS: Dividends payable to shares registered with Euronext VPS will be distributed on or about 17 December, 2021.Key information relating to the dividend to be paid by Flex LNG Ltd. for the third quarter 2021:Note to shareholders registered in Euronext VPS, the Norwegian Central Security Depository: Due to implementation of the Central Securities Depository Regulation (CSDR) in Norway, we have been informed that the payment date to shares registered in Euronext VPS will change from previous quarters. See details below.  Dividend amount: $0.75 Declared currency: USD. Dividends payable to shares registered with Euronext VPS will be distributed in NOK. Last day including right: 30 November, 2021 Ex-date: 1 December, 2021 Record date: 2 December, 2021 Payment...

Continue reading

Landsbankinn hf.: Landsbankinn issues green bonds in euros

Today, Landsbankinn concluded a sale of green bonds in the amount of EUR 300 million with maturity in May 2026. The bonds have a fixed coupon of 0.75% and were sold at terms equivalent to 95 basis point spread over mid-swap market rate. The bonds will be issued under the Bank‘s EMTN programme with reference to its sustainable finance framework, reviewed by Sustainalytics. The bonds will be admitted to trading on Euronext Dublin as of 25 November 2021. Managers were ABN AMRO, J.P. Morgan, Natixis and NatWest Markets.

Continue reading

Flow Announces Results of 2021 Annual General Meeting

TORONTO, Nov. 16, 2021 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV: FW) (“Flow Capital” or the “Company”) announces the results of its 2021 Annual and Special Meeting (“AGM”) of shareholders held on Monday, November 15, 2021, in Toronto, Canada. Shareholders approved all the resolutions detailed in the management information circular of the Company dated September 30, 2021 (the “Circular”), namely:Electing all the nominees to the Board of Directors of the Company Appointing Dale Matheson Carr-Hilton Labonte LLP as auditor of the Company for the ensuing year and authorizing the directors to determine the auditor’s compensation; Approving the 2021 Omnibus Equity Incentive Plan for the Company and the granting of certain restricted share unit awards thereunder.A total of 4,200,473 common shares of the Company were...

Continue reading

Evergold’s Golden Lion Drilling Yields the Highest Grades Yet Seen on the Property, Multiple High-Grade Intercepts Including 2.8 m of 10.4 g/t Gold, 651 g/t Silver, 11% Zinc, 4% Lead, Within 11.3 m of 5.4 g/t Gold, 62 g/t Silver, 3% Zinc, 1% Lead

Figure 1Drill Section 23-24-25Figure 2Drill Section 17-18Figure 3Drill Section 20-21-22Figure 4Drilling on TopographyFigure 5Geological PlanTORONTO, Nov. 16, 2021 (GLOBE NEWSWIRE) —  Evergold Corp. (“Evergold” or the “Company”) (TSX-V:EVER, WKN:A2PTHZ) is pleased to report by far the highest grades of gold, silver, zinc and lead ever achieved in drilling at the GL1 Main target, located on the Company’s Golden Lion property in the Toodoggone epithermal district, northern British Columbia, Canada. Assay results for drill section 23-24-25 (Figure 1), encompassing the final 3 holes of the program, definitively establish that the GL1 Main Zone carries high grades of gold, silver and base metals within a broader envelope of moderate grade mineralization,...

Continue reading

Ensurge Micropower ASA – Third Quarter 2021 Results Webcast

Oslo, 16 November 2021 Following the release of the Company’s third quarter 2021 interim report and financial statements, Ensurge Micropower ASA (“Ensurge”) will hold a web conference on Wednesday, 17 November 2021 at 8:00am Central European Time. The presentation by CEO Kevin Barber will be held in English and discuss the company’s technology, manufacturing, and go-to-market activities. At the time of the event, the conference can be accessed at https://channel.royalcast.com/landingpage/hegnarmedia/20211117_1/ Following the event, a recording will be available on the Company’s investor relations website at https://ensurge.com/investor-relations/presentations-webcasts/About Ensurge Ensurge is Energizing Innovation™ with ultrathin, flexible, and safe energy storage solutions for wearable devices, connected...

Continue reading

Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update

NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) — Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced results for the third quarter ended September 30, 2021. Recent HighlightsHosted a virtual science review to discuss the scientific rationale and evidence for PT00114 in the treatment of Depression, Anxiety, PTSD and Addiction. Replay available at www.protagenic.com. Hosted a key opinion leader (KOL) webinar focused on PT00114 for the regulation of stress in patients with Depression, PTSD, Anxiety and Addiction. Replay available at www.protagenic.com. Received FDA comment to provide clinical sites with ready-to-inject clinical vials of PT00114; to result in IND refiling in the fourth quarter“During the third quarter and...

Continue reading

Todos Medical’s Provista Laboratory to Boost Top Line Through New Atlanta-based Reference Lab Agreement for COVID PCR, cPass Neutralizing Antibody & Respiratory Pathogen Panel Tests

New York, NY, and Tel Aviv, ISRAEL, Nov. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its wholly-owned CLIA/CAP laboratory Provista Diagnostics has entered into a new reference lab agreement with an Atlanta-based CLIA laboratory (the “New Client”). Provista will be providing COVID PCR, cPass Neutralizing Antibody and Respiratory Pathogen Panel (RPP) testing with local sample collection expected to yield less than 12-hour turnaround times. The Company expects to initially add 2,000 COVID PCR tests monthly, and increase the overall production on a monthly basis. Due to the steadily increasing demand for combined COVID and RPP testing for symptomatic pediatric patients, Provista’s highly...

Continue reading

BioSig Initiates Artificial Intelligence Development Program with Technion – Israel Institute of Technology

Company partners with the leading academic institution on research and development of AI-driven methods for atrial fibrillation procedures Westport, CT, Nov. 16, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company entered into a feasibility study with The Technion Research & Development Foundation Ltd. Based in Haifa, Israel, Technion – Israel Institute of Technology is a public research university offering degrees in science, engineering, and related fields, such as medicine, industrial management, and education. Over the years, the Technion established itself...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.